UK IHT Protection of Secret Formulas: Inheritance of Coca-Cola Style Trade Secrets

Inheritance tax (IHT) in the United Kingdom applies not only to physical assets and cash but also to intangible property, including trade secrets, proprietary formulas, and intellectual property (IP). For families or businesses holding assets akin to the Coca-Cola formula—a secret recipe estimated to be worth over $98 billion as part of the company’s brand value (Interbrand, 2023, Best Global Brands report)—the challenge of transferring these assets across generations without triggering a 40% IHT charge is acute. HM Revenue & Customs (HMRC) data for 2022/23 shows that total IHT receipts reached £7.1 billion, a 12% increase from the previous year, reflecting rising asset valuations and stricter enforcement (HMRC, 2024, IHT Statistics). For UK-domiciled individuals or those with UK-situs trade secrets, the default 40% charge on estates exceeding the £325,000 nil-rate band can force the sale or disclosure of closely guarded formulas to pay the tax bill. This article examines the specific legal and valuation complexities of passing secret formulas through UK inheritance, using anonymised case studies of Mrs X, a food manufacturer, and Mr Y, a chemical engineer, to illustrate practical strategies such as business property relief, trust structures, and post-death share valuations.

The Legal Classification of Trade Secrets Under UK IHT

Trade secrets are classified as intangible property under the Inheritance Tax Act 1984 (IHTA 1984), falling within the definition of “property” in section 272. For IHT purposes, a secret formula is not a physical asset but a right with economic value, and its situs (location) is determined by the residence of the owner or the place where the right is enforceable. Under UK law, a trade secret is protected by the common law of confidence and the Trade Secrets (Enforcement, etc.) Regulations 2018, implementing the EU Trade Secrets Directive. HMRC treats the value of a secret formula as part of the deceased’s estate, requiring a professional valuation at the date of death.

The key distinction from patents or registered trademarks is that trade secrets have no fixed term and no public registry. This creates valuation uncertainty, as HMRC may argue for a higher value based on projected licensing income, while the estate may argue for a lower value due to secrecy risk. In the case of Mrs X, who owned a family food business with a secret spice blend, HMRC initially assessed the formula’s value at £2.4 million based on a 10-year discounted cash flow model. The estate successfully reduced this to £850,000 by demonstrating that the secret could be reverse-engineered within three years, citing industry benchmarks from the Food and Drink Federation (FDF, 2022, UK Food Sector Report).

H3: Situs Rules for Secret Formulas Held by Non-UK Domiciliaries

For individuals not domiciled in the UK, only UK-situs assets are subject to IHT. A trade secret is deemed UK-situs if the owner is UK-resident at death or if the formula is physically stored or legally enforceable in the UK. For Mr Y, a Swiss-domiciled chemical engineer who held a UK patent and a separate secret catalyst formula, HMRC argued that the catalyst was UK-situs because the research was conducted at a UK laboratory. The estate countered by proving the formula was stored only in a Swiss vault and licensed to a German manufacturer, resulting in a 70% reduction in the IHT charge.

Business Property Relief (BPR) for Secret Formula Assets

Business Property Relief (BPR) under IHTA 1984, sections 103-114, is the most powerful tool for reducing IHT on trade secrets, offering up to 100% relief on relevant business property. To qualify, the secret formula must be held as part of a qualifying business, not as an investment asset. HMRC’s manual (IHTM25131) distinguishes between a trading business and a holding company: if the formula is merely licensed out without active management, it may be treated as an investment, attracting only 50% relief or none at all.

Mrs X’s case illustrates this distinction. Her spice blend was integral to her manufacturing business, which employed 12 staff and produced 15,000 units per month. The entire business, including the secret formula, qualified for 100% BPR, saving approximately £960,000 in IHT. However, HMRC challenged the relief on the grounds that the formula could be separated from the business. The estate won by demonstrating that the formula was essential to the business’s trading activity, citing the HMRC v. Brander (2003) precedent, where woodlands with sporting rights were held to be trading assets.

H3: The “Wholly or Mainly” Test for Mixed Businesses

Where a business holds both trading and investment assets, the “wholly or mainly” test applies. If more than 50% of the business value derives from investment activities, BPR is lost entirely. For a secret formula portfolio, this is critical: if the deceased owned the formula separately and only collected royalties, it would be an investment. Mr Y faced this issue—his catalyst formula generated £180,000 annually in licensing fees with no active business operations. The estate had to restructure by incorporating a trading company that used the formula in contract manufacturing, thereby qualifying for 100% BPR on the shares.

Valuation Methodologies for Secret Formulas in Probate

Valuing a secret formula for IHT purposes requires a specialist approach, as there is no open market for unique trade secrets. HMRC accepts three primary methods: the income approach (discounted cash flow), the market approach (comparable licensing deals), and the cost approach (replacement cost). The income approach is most common, but HMRC often disputes discount rates and secrecy decay assumptions.

In Mrs X’s probate, the estate used a 12% discount rate based on the weighted average cost of capital for UK food manufacturers (Bank of England, 2023, Corporate Finance Data). HMRC argued for 8%, which would have doubled the valuation. The estate prevailed by introducing evidence that 40% of food trade secrets are leaked within five years, citing a study by the Intellectual Property Office (IPO, 2021, Trade Secret Protection in the UK). The final valuation of £850,000 was based on a 5-year cash flow with a 35% probability of secrecy loss.

For Mr Y, the estate used the market approach, benchmarking against three publicly disclosed chemical licensing agreements in the Royal Society of Chemistry journal (2022). The comparable deals showed a median royalty rate of 4.7% of net sales, applied to the projected sales of the licensee. HMRC accepted this method but disputed the sales projection, settling at £1.2 million versus the original £2.8 million assessment.

Trust Structures for Protecting Secret Formulas Across Generations

Trusts are a common vehicle for passing trade secrets while controlling disclosure and mitigating IHT. A discretionary trust allows the settlor to transfer the formula during lifetime, removing it from the estate after seven years (potentially exempt transfer, PET). However, the trust itself faces IHT charges every ten years (10-year anniversary charge) at a maximum rate of 6% on values exceeding the nil-rate band.

Mrs X established a discretionary trust for her spice blend in 2018, gifting the formula shares to her three children. The gift was a PET, and she survived the seven-year period, saving £960,000 in IHT. The trust deed included a “secret protector” clause, appointing a solicitor as the guardian of the formula, ensuring only one child at a time could access the full recipe. This structure avoided the need for probate disclosure of the formula.

For Mr Y, a non-UK domiciliary, a excluded property trust was used. Since the formula was held offshore (Swiss vault), and Mr Y was not UK-domiciled, the trust assets were outside the UK IHT net. However, HMRC challenged the situs, arguing that the UK patent was a separate asset. The estate settled by transferring the patent to the trust, paying a small IHT charge on the patent value only.

Post-death variations (deeds of variation) under IHTA 1984, section 142, allow beneficiaries to redirect assets within two years of death, effectively rewriting the will for IHT purposes. This is particularly useful for secret formulas held in company shares, where the share value may need to be adjusted for minority discounts or lack of marketability.

In Mrs X’s estate, the shares in her private limited company were valued at £3.2 million by HMRC, including the formula. The estate instructed a specialist valuer who applied a 35% minority discount (since no one beneficiary held over 50%) and a 15% lack-of-marketability discount, reducing the share value to £1.7 million. The deed of variation then redirected the shares to a trust, saving an additional £600,000 in IHT.

For Mr Y, the estate used a deed of variation to redirect the formula’s licensing income to a charitable trust, qualifying for 100% charitable relief on that portion. HMRC accepted the variation, provided the charity used the income for research purposes. The estate also claimed a 10% discount for the formula’s dependency on Mr Y’s personal expertise, arguing that without him, the formula’s value dropped by 20% (IPO, 2021, Trade Secret Valuation Guidelines).

Cross-Border IHT and Double Taxation Treaty Relief

Double taxation treaties between the UK and other countries can prevent the same secret formula from being taxed twice. The UK has treaties with over 130 jurisdictions, including the US, Switzerland, and Singapore. For trade secrets, the treaty typically allocates taxing rights to the country where the owner is resident at death, unless the formula is linked to a permanent establishment.

Mr Y’s estate benefited from the UK-Switzerland Double Taxation Treaty (2012). HMRC initially assessed the formula as UK-situs, but the estate argued that the Swiss-resident owner and the Swiss storage location gave taxing rights to Switzerland, where no IHT equivalent exists. The treaty’s “other property” clause (Article 22) allocated the formula to Switzerland, saving £480,000 in UK IHT. The estate also filed a claim under the Mutual Agreement Procedure, which HMRC accepted within 14 months.

For Mrs X, who was UK-domiciled, no treaty relief was available. However, her children were US residents, and the estate used the UK-US Estate Tax Treaty to ensure that the US did not impose a second layer of tax on the inherited shares. The treaty’s credit provisions allowed the US to offset UK IHT against US estate tax, avoiding double taxation on the £1.7 million share value.

HMRC’s Share Valuation Division (SVD) is the primary body that challenges valuations of secret formulas and private company shares. They employ forensic accountants and industry specialists who scrutinise discount rates, growth projections, and secrecy assumptions. Engaging a chartered surveyor or a forensic accountant with trade secret experience is essential.

In Mrs X’s case, the SVD initially rejected the estate’s valuation, proposing a 20% higher figure. The estate commissioned a report from a specialist IP valuer accredited by the Royal Institution of Chartered Surveyors (RICS, 2023, Valuation of Intangible Assets). The report included a Monte Carlo simulation of secrecy leakage, showing a 68% probability that the formula would be disclosed within 7 years. The SVD accepted this analysis, settling at the estate’s original figure.

For Mr Y, the SVD challenged the minority discount applied to his shares. The estate’s valuer cited the HMRC v. Gray (2018) case, where a 30% discount was upheld for a single-asset company. The SVD conceded, but required a 5% premium for the formula’s strategic value, resulting in a 25% net discount. The final settlement saved £300,000 in IHT.

FAQ

Q1: Can a trade secret be valued at nil for IHT purposes if it is kept completely secret?

No. HMRC treats any asset with economic value as part of the estate, even if it is not publicly known. In a 2021 case, HMRC successfully argued that a secret recipe for a cleaning product had value because it generated £50,000 per year in licensing income. The estate’s claim of nil value was rejected, and a settlement of £180,000 was reached. However, if the secret has no commercial application and no income history, a nominal value of £1 to £100 may be accepted.

Q2: What happens if the formula is disclosed during the probate process?

Disclosure during probate can trigger a loss of trade secret protection, potentially reducing the asset’s value. The executor must take steps to maintain confidentiality, such as filing a sealed valuation report with HMRC and using a trusted third-party custodian. In a 2022 case, a family had to pay IHT on the full pre-disclosure value of £1.2 million after the formula was accidentally published in probate documents, despite the formula’s value dropping to £0 after disclosure.

Q3: Can I use life insurance to cover IHT on a secret formula?

Yes. A whole-of-life insurance policy written in trust can provide immediate liquidity to pay the IHT bill without forcing a sale or disclosure of the formula. For a formula valued at £2 million, the IHT charge would be £800,000. A level-term policy for that amount, written in a discretionary trust, would cost approximately £4,000 to £6,000 per year for a 60-year-old non-smoker (based on UK market rates as of 2024). The policy proceeds are paid outside the estate, avoiding additional IHT.

References

HMRC, 2024, Inheritance Tax Statistics: 2022/23 Receipts and Nil-Rate Band Data
Interbrand, 2023, Best Global Brands Report: Coca-Cola Brand Valuation
Intellectual Property Office (IPO), 2021, Trade Secret Protection in the UK: Valuation and Leakage Study
Royal Institution of Chartered Surveyors (RICS), 2023, Valuation of Intangible Assets: Professional Standards Guidance